Wordt geladen...
Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side‐effects and stabilize plasma glucose levels.
Bewaard in:
| Gepubliceerd in: | Clin Case Rep |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7813030/ https://ncbi.nlm.nih.gov/pubmed/33489173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3514 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|